BusinessWellDoc Announces Providence Health & Services’ Implementation of BlueStar® Digital Therapeutic in a Pilot Program for Individuals with Type 2 DiabetesBy Nasdaq OMXApr 3, 2018, 1:01 PM UTC
BusinessVoluntis and WellDoc Announce Partnership to Combine Diabetes Digital Therapeutic OfferingsBy Nasdaq OMXJan 9, 2018, 2:02 PM UTC
BusinessWellDoc Validates Potential of Its Digital Therapeutic, BlueStar®, to Significantly Reduce Healthcare CostsBy Nasdaq OMXJan 4, 2018, 2:00 PM UTC
BusinessDigital Therapeutics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2015–2025By Nasdaq OMXNov 14, 2017, 10:04 AM UTC
BusinessIQVIA Institute Rates WellDoc’s BlueStar® as “Top App” in Clinical Diabetes TreatmentBy Nasdaq OMXNov 13, 2017, 3:52 PM UTC
BusinessUPDATE -- WellDoc Diabetes Thought Leaders Publish Article Highlighting Need for Integration of Digital Health Tools into Diabetes Educators’ PracticesBy Nasdaq OMXAug 28, 2017, 1:48 PM UTC
BusinessFor Immediate Release WellDoc Diabetes Thought Leaders Publish Article Highlighting Need for Integration of Digital Health Tools into Diabetes Educators’ PracticesBy Nasdaq OMXAug 28, 2017, 1:00 PM UTC
BusinessWellDoc® Provides BlueStar® to New Class in American Diabetes Association of Maryland’s “The Fabulous YOU!” ProgramBy Nasdaq OMXJun 27, 2017, 1:00 PM UTC
